StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > BioPub Webcast

<< Previous

Bullboard Posts

Next >>

Comment by brad129on Feb 18, 2022 7:41pm

129 Views

Post# 34443856

RE:RE:RE:RE:RE:RE:BioPub Webcast

Well there are many, many people who can afford it, I rent out my lake house for $5000 a week and there is a waiting list for it. People spend on what is priority to them

TrippinAgain123 wrote: Maybe your rich but many average Canadians are struggling to get by and would rather opt on something free and use the 2k for their family in most cases, this is a reality.

<< Previous

Bullboard Posts

Next >>

Umicore hits pause on Canadian battery materials plant construction